In a remarkable turn of events, Altimmune (NASDAQ: ALT) witnessed a staggering 27% surge in its stock price this morning,…
Read More »Biotech
Gilead Sciences (NASDAQ: GILD) witnessed a notable 4% surge in its stock price this morning, driven by a confluence of…
Read More »Shares of Day One Biopharmaceuticals (NASDAQ: DAWN) surged 11.3% this morning, reflecting strong investor confidence fueled by a series of…
Read More »CRISPR Therapeutics (NASDAQ: CRSP) saw a notable increase in its stock price, rising by 3.6% even though there was no…
Read More »Avidity Biosciences (NASDAQ: RNA) has seen a significant surge in its stock price, opening nearly 5% higher today. This increase…
Read More »Vanda Pharmaceuticals (NASDAQ: VNDA) stock is experiencing a significant increase in early trading following two notable announcements. The first involves…
Read More »MindMed, a company specializing in psychedelic medicine, experienced a significant drop in its stock price, falling 15% following news regarding…
Read More »Annexon Biosciences (NASDAQ: ANNX) saw a significant pre-market surge of 44% following the announcement of positive topline results from their…
Read More »Structure Therapeutics (NASDAQ: GPCR) has seen a significant surge in pre-market trading, driven by several key factors that have captivated…
Read More »Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company, saw its stock price surge significantly today despite the absence of any…
Read More »